Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease

Acta Pharmacol Sin. 2022 Jan;43(1):10-14. doi: 10.1038/s41401-021-00629-0. Epub 2021 Mar 17.

Abstract

Metabolic-associated fatty liver disease (MAFLD) is the most common metabolic disease with a global prevalence of 25%. While MAFLD is serious and incurable at the later stage, it can be controlled or reversed at the early stage of hepatosteatosis originating from unhealthy diets. Recent laboratory evidence implicates a critical role of the mammalian target of rapamycin (mTOR)-autophagy signaling pathway in the pathogenesis of MAFLD induced by a high-fructose diet mimicking the overconsumption of sugar in humans. This review discusses the possible molecular mechanisms of mTOR-autophagy-endoplasmic reticulum (ER) stress in MAFLD. Based on careful analysis of recent studies, we suggest possible new therapeutic concepts or targets that can be explored for the discovery of new anti-MAFLD drugs.

Keywords: ER stress; MAFLD; autophagy; high-fructose diet; mTOR; metabolic syndrome.

Publication types

  • Review

MeSH terms

  • Autophagy*
  • Endoplasmic Reticulum Stress
  • Fructose / adverse effects
  • Fructose / metabolism*
  • Humans
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Fructose
  • MTOR protein, human
  • TOR Serine-Threonine Kinases